Janux Therapeutics, Inc. Insider Transactions
Purchase
Sell
Janux Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Meyer Andrew Hollman
Chief Business Officer |
Sell | 400 @ $32.60 | $13.04 K | 82,139 | 05/01/2025 | 05/02/2025 | |
|
Meyer Andrew Hollman
Chief Business Officer |
Sell | 2,933 @ $31.95 | $93.70 K | 82,539 | 05/01/2025 | 05/02/2025 | |
|
Meyer Andrew Hollman
Chief Business Officer |
Sell | 3,334 @ $30.00 | $100.02 K | 82,139 | 04/21/2025 | 04/23/2025 | |
|
RA CAPITAL MANAGEMENT, L.P.
Director, 10 percent owner: |
Buy | 110,206 @ $31.02 | $3.42 M | 10,141,287 | 03/07/2025 | 03/07/2025 | |
|
RA CAPITAL MANAGEMENT, L.P.
Director, 10 percent owner: |
Buy | 372,093 @ $30.78 | $11.45 M | 10,031,081 | 03/06/2025 | 03/07/2025 | |
|
RA CAPITAL MANAGEMENT, L.P.
Director, 10 percent owner: |
Buy | 304,287 @ $30.56 | $9.30 M | 9,621,533 | 03/05/2025 | 03/07/2025 | |
|
RA CAPITAL MANAGEMENT, L.P.
Director, 10 percent owner: |
Buy | 37,455 @ $31.30 | $1.17 M | 9,658,988 | 03/05/2025 | 03/07/2025 | |
|
Meyer Andrew Hollman
Chief Business Officer |
Sell | 2,433 @ $31.88 | $77.58 K | 83,040 | 03/03/2025 | 03/05/2025 | |
|
Meyer Andrew Hollman
Chief Business Officer |
Sell | 901 @ $32.85 | $29.60 K | 82,139 | 03/03/2025 | 03/05/2025 | |
|
Meyer Andrew Hollman
Chief Business Officer |
Sell | 816 @ $42.77 | $34.90 K | 82,239 | 02/03/2025 | 02/05/2025 | |
|
Meyer Andrew Hollman
Chief Business Officer |
Sell | 100 @ $43.60 | $4.36 K | 82,139 | 02/03/2025 | 02/05/2025 | |
|
Meyer Andrew Hollman
Chief Business Officer |
Sell | 2,418 @ $42.08 | $101.74 K | 83,055 | 02/03/2025 | 02/05/2025 | |
| Sell | 5,000 @ $60.00 | $300.00 K | 293,054 | 01/07/2025 | 01/08/2025 | ||
|
Meyer Andrew Hollman
Chief Business Officer |
Sell | 2,922 @ $53.76 | $157.08 K | 92,551 | 01/02/2025 | 01/03/2025 | |
|
Meyer Andrew Hollman
Chief Business Officer |
Sell | 1,000 @ $56.78 | $56.78 K | 82,339 | 01/02/2025 | 01/03/2025 | |
|
Meyer Andrew Hollman
Chief Business Officer |
Sell | 200 @ $57.37 | $11.47 K | 82,139 | 01/02/2025 | 01/03/2025 | |
|
Meyer Andrew Hollman
Chief Business Officer |
Sell | 3,444 @ $55.76 | $192.03 K | 83,339 | 01/02/2025 | 01/03/2025 | |
|
Meyer Andrew Hollman
Chief Business Officer |
Sell | 5,768 @ $54.51 | $314.42 K | 86,783 | 01/02/2025 | 01/03/2025 | |
| Sell | 25,000 @ $56.19 | $1.40 M | 217,054 | 12/24/2024 | 12/27/2024 | ||
| Sell | 15,000 @ $67.00 | $1.01 M | 242,054 | 12/03/2024 | 12/03/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Janux Therapeutics, Inc. FAQ's
The list of insiders at Janux Therapeutics, Inc. includes Lichter Jay, Avalon Ventures XI, L.P., RA CAPITAL MANAGEMENT, L.P., Campbell David Alan, Meyer Andrew Hollman.
Insiders have sold a total of 1.89 M Janux Therapeutics, Inc. shares in the last 12 months for a total of 88.53 M sold.
The following insiders have sold Janux Therapeutics, Inc. shares in the last 12 months: Lichter Jay ($178.08 K), Avalon Ventures XI, L.P. ($81.83 M), Campbell David Alan ($5.34 M), Meyer Andrew Hollman ($1.19 M),
Insiders have purchased a total of 2.02 M Janux Therapeutics, Inc. shares in the last 12 months for a total of 79.04 M.
The following insiders have purchased Janux Therapeutics, Inc. shares in the last 12 months: RA CAPITAL MANAGEMENT, L.P. ($79.04 M),